Previous Page  92 / 225 Next Page
Information
Show Menu
Previous Page 92 / 225 Next Page
Page Background

92

· DOS Abstracts

Medium to Long-term functionality and survival of

HemiCap for hallux rigidus

Mads Holm Møller, Pernille Henszelman Jørsboe, Michael Stage Pedersen, Mo-

stafa Benyahia, Thomas Kallemose, Jeannette Østergaard Penny

Ortopædkirurgisk afdeling, Hvidovre

Background:

Hallux rigidus treated with HemiCap arthroplasty aims to reduce

pain and preserve motion, but no mid/long term results exist.

Purpose / Aim of Study:

To examine the functionality, pain and the revision

rate of HemiCap implants.

Materials and Methods:

106 patients were operated with HemiCap (n=114)

from 2006-2014, median age 53 years (16-80), 37 dorsal flange (DF) im-

plants. A retrospective journal review collected revision data. Preoperative ar-

throsis degree, hallux valgus (HV), intermetatarsal (IM) and Distal Metaphy-

seal Articular Angle (DMAA) were measured. Preoperative pain levels by Visuel

Analog Skala (VAS 1-10), American Orthopaedic Foot and Ankle Score (AOFAS

0-100 points) and Range of Motion (ROM) were available for 51 patients. Of

the initial 106, 70 were eligible for reexamination and 47 partook in a cross sec-

tional follow up where Self-Reported Foot and Ankle Score (SEFAS 0-48 points)

was added to the previous measures. Statistics: Kaplan-Meier survival analysis,

Cox-regression and paired t-tests.

Findings / Results:

At 3, 5 and 7 years, the implant survival was 85%, 83%

and 78%. All revised due to pain. DF, gender, preoperative arthrosis degree, HV,

IM or DMAA did not influence the result. At mean 5 year follow up (n=47)

mean (sd) dorsal ROM was 46(17) degrees, AOFAS was 84(9), VAS 2(1) and

SEFAS 42(6) points. The DF made no significant difference for ROM or PROMs.

23 with pre- op data were re-examined and preoperative dorsal ROM changed

from 21(6) to 42(18) degrees, VAS from 7(2) to 2(2) and AOFAS from 61(11)

to 87(11) (p < 0.001).

Conclusions:

The survival rate was acceptable. No predictors influenced im-

plant failure and new design with dorsal flange is not evident clinically. Un-re-

vised patients have significantly less pain, greater ROM, and better foot and

ankle function than preoperatively, but data are biased by missing numbers.

No conflicts of interest reported

44.